Marketing and commercial challenges for anticancer products

被引:0
作者
Stevens, DM
机构
来源
IN VIVO | 1996年 / 10卷 / 02期
关键词
cancer; commercialisation; drug administration; ethical concerns; formulanes; marketing; medical education; off-label; oncology; pharmaceutical companies; pharmacoeconomic; pricing; referrals; reimbursement; sales; supportive care;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Traditional marketing techniques that are employed by pharmaceutical manufacturers are not adequate in the oncology setting. Many unique characteristics of this therapeutic area create challenges to the marketing and sales teams responsible for selling anticancer and cancer-therapy support products. There is a high burden on those marketing oncology products to provide vast amounts of information about their products, in a timely manner; to various groups of health care providers, while functioning within established legal boundaries. Pharmaceutical companies, through their sales and marketing efforts, are working to provide the information health care providers need to make patient management decisions and prevent the health care environment from restricting physician and patient choices.
引用
收藏
页码:261 / 264
页数:4
相关论文
empty
未找到相关数据